Cargando…

Therapeutic cancer vaccines and combination immunotherapies involving vaccination

Recent US Food and Drug Administration approvals of Provenge(®) (sipuleucel-T) as the first cell-based cancer therapeutic factor and ipilimumab (Yervoy(®)/anticytotoxic T-lymphocyte antigen-4) as the first “checkpoint blocker” highlight recent advances in cancer immunotherapy. Positive results of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nguyen, Trang, Urban, Julie, Kalinski, Pawel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918241/ https://www.ncbi.nlm.nih.gov/pubmed/27471705 http://dx.doi.org/10.2147/ITT.S40264

Ejemplares similares

Therapeutic Vaccines and Cancer Immunotherapy
por: Bhatt, Darshak, et al.
Publicado: (2020)

Stay on Target: Reengaging Cancer Vaccines in Combination Immunotherapy
por: Wolfson, Benjamin, et al.
Publicado: (2021)

Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways
por: Zhu, Zhi, et al.
Publicado: (2022)

Therapeutic vaccination immunomodulation: forming the basis of all cancer immunotherapy
por: Coventry, Brendon J.
Publicado: (2019)

Developments in HIV-1 immunotherapy and therapeutic vaccination
por: Smith, Peter Lawrence, et al.
Publicado: (2014)

Tumor antigens for cancer immunotherapy: therapeutic potential of xenogeneic DNA vaccines
por: Srinivasan, Roopa, et al.
Publicado: (2004)

DNA vaccine for cancer immunotherapy
por: Yang, Benjamin, et al.
Publicado: (2015)

Combining Cancer Vaccines with Immunotherapy: Establishing a New Immunological Approach
por: Kim, Chang-Gon, et al.
Publicado: (2021)

Therapeutic Cancer Vaccines in Combination with Conventional Therapy
por: Andersen, Mads Hald, et al.
Publicado: (2010)

DC-Based Vaccines for Cancer Immunotherapy
por: Fu, Chunmei, et al.
Publicado: (2020)

mRNA vaccine for cancer immunotherapy
por: Miao, Lei, et al.
Publicado: (2021)

Immunotherapy and therapeutic vaccines in prostate cancer: an update on current strategies and clinical implications
por: Singh, B Harpreet, et al.
Publicado: (2014)

Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
por: Segura-Collar, Berta, et al.
Publicado: (2023)

B-cell epitope peptide cancer vaccines: a new paradigm for combination immunotherapies with novel checkpoint peptide vaccine
por: Kaumaya, Pravin TP
Publicado: (2020)

Combination Immunotherapy: Taking Cancer Vaccines to the Next Level
por: Grenier, Jeremy M., et al.
Publicado: (2018)

RNA-Based Vaccines in Cancer Immunotherapy
por: McNamara, Megan A., et al.
Publicado: (2015)

Opportunities for Conventional and In Situ Cancer Vaccine Strategies and Combination with Immunotherapy for Gastrointestinal Cancers, A Review
por: Bouzid, Rachid, et al.
Publicado: (2020)

Cancer Vaccine Immunotherapy with RNA-Loaded Liposomes
por: Sayour, Elias J., et al.
Publicado: (2018)

Vaccine-Based Immunotherapy for Head and Neck Cancers
por: Beyaert, Simon, et al.
Publicado: (2021)

Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy
por: Zhu, Guizhi, et al.
Publicado: (2017)

Nanoparticle-Based Vaccine Delivery for Cancer Immunotherapy
por: Park, Yeong-Min, et al.
Publicado: (2013)

Immune Modulation by Chemotherapy or Immunotherapy to Enhance Cancer Vaccines
por: Weir, Genevieve M., et al.
Publicado: (2011)

Mycobacteria-Based Vaccines as Immunotherapy for Non-urological Cancers
por: Noguera-Ortega, Estela, et al.
Publicado: (2020)

Dexosomes as a cell-free vaccine for cancer immunotherapy
por: Nikfarjam, Sepideh, et al.
Publicado: (2020)

Research progress on dendritic cell vaccines in cancer immunotherapy
por: Yu, Jifeng, et al.
Publicado: (2022)

Directing T-Cell Immune Responses for Cancer Vaccination and Immunotherapy
por: Smith, Peter Lawrence, et al.
Publicado: (2021)

Engineering neoantigen vaccines to improve cancer personalized immunotherapy
por: Liu, Zaoqu, et al.
Publicado: (2022)

Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy
por: Ruzzi, Francesca, et al.
Publicado: (2023)

Cancer Vaccines: Toward the Next Breakthrough in Cancer Immunotherapy
por: Igarashi, Yuka, et al.
Publicado: (2020)

Therapeutic exosomal vaccine for enhanced cancer immunotherapy by mediating tumor microenvironment
por: Lv, Fangfang, et al.
Publicado: (2021)

Nanotechnology in cervical cancer immunotherapy: Therapeutic vaccines and adoptive cell therapy
por: Zhou, Xuyan, et al.
Publicado: (2022)

Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
por: Guo, Zong Sheng, et al.
Publicado: (2019)

Reinvigorating therapeutic cancer vaccines
por: Robles-Oteiza, Camila, et al.
Publicado: (2022)

Immunotherapy For Ovarian Cancer: Recent Advances And Combination Therapeutic Approaches
por: Palaia, Innocenza, et al.
Publicado: (2020)

Vaccination and immunotherapies in neuroimmunological diseases
por: Winkelmann, Alexander, et al.
Publicado: (2022)

Recent Advances of Vaccine Adjuvants for Infectious Diseases
por: Lee, Sujin, et al.
Publicado: (2015)

Recent Advances in Cancer Immunotherapy with a Focus on FDA-Approved Vaccines and Neoantigen-Based Vaccines
por: Hargrave, Anna, et al.
Publicado: (2023)

Prospects for immunotherapy and vaccines against Cryptosporidium
por: Mead, Jan R
Publicado: (2014)

Neoantigen vaccine: an emerging tumor immunotherapy
por: Peng, Miao, et al.
Publicado: (2019)

The future of cancer immunotherapy: DNA vaccines leading the way
por: Pandya, Aanshi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_167t3k6m4g8tkdjrcang8j7b2c